ANDREA ORR: Open Payments
NPI 1659001832 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 19 payments from 10 companies in 2025. Trend: 2023 $426 · 2024 $1,939 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 5 | $98 |
| Sumitomo Pharma America, Inc. | 4 | $96 |
| PFIZER INC. | 2 | $69 |
| Antares Pharma, Inc. | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Janssen Biotech, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| ConvaTec Inc. | 1 | $16 |
Products named: AVEED, GEMTESA, XTANDI, XYOSTED, PLUVICTO, ERLEADA, General - Female SUI, ADSTILADRIN.
Industry payments across NC — which companies pay providers there.
